Design, display and immunogenicity of HIV1 gp120 fragment immunogens on virus-like particles

被引:4
|
作者
Purwar, Mansi [1 ]
Pokorski, Jonathan K. [2 ,3 ,6 ]
Singh, Pranveer [1 ,7 ]
Bhattacharyya, Sanchari [1 ]
Arendt, Heather [4 ]
DeStefano, Joanne [4 ]
La Branche, Celia C. [5 ]
Montefiori, David C. [5 ]
Finn, M. G. [2 ,3 ,8 ]
Varadarajan, Raghavan [1 ]
机构
[1] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India
[2] Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA
[3] Scripps Res Inst, Skaggs Inst Chem Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA
[4] Int AIDS Vaccine Initiat, Brooklyn, NY 11226 USA
[5] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA
[6] Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA
[7] Mahatma Gandhi Cent Univ Bihar, Dept Zool, Motihari 845401, Bihar, India
[8] Georgia Inst Technol, Sch Chem & Biochem, 901 Atlantic Dr, Atlanta, GA 30332 USA
基金
美国国家卫生研究院;
关键词
Protein stability; Immune focusing; Neutralizing antibodies; Vaccine; Nanoparticles; OUTER-DOMAIN; DISULFIDE BONDS; NEUTRALIZING ANTIBODIES; TYPE-1; VACCINE; CD4; CORE; SITE; GLYCOSYLATION; GLYCOPROTEIN;
D O I
10.1016/j.vaccine.2018.07.032
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The broadly neutralizing antibody against HIV-1, b12, binds to the CD4 binding site (CD4bs) on the outer domain (OD) of the gp120 subunit of HIV-1 Env. We have previously reported the design of an E. coli expressed fragment of HIV-1 gp120, b122a, containing about 70% of the b12 epitope with the idea of focusing the immune response to this structure. Since the b122a structure was found to be only partially folded, as assessed by circular dichroism and protease resistance, we attempted to stabilize it by the introduction of additional disulfide bonds. One such mutant, b122a1-b showed increased stability and bound b12 with 30-fold greater affinity as compared to b122a. Various b122a and OD fragment proteins were displayed on the surface of Qp virus-like particles. Sera raised against these particles in six-month long rabbit immunization studies could neutralize Tier1 viruses across different subtypes with the best results observed with b122a1-b displayed particles. Significantly higher amounts of antibodies directed towards the CD4bs were also elicited by particles displaying b122a1-b. This study highlights the ability of fragment immunogens to focus the antibody response to the conserved CD4bs of HIV-1. (C) 2018 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6345 / 6353
页数:9
相关论文
共 50 条
  • [1] A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120
    Crooks, Emma T.
    Moore, Penny L.
    Franti, Michael
    Cayanan, Charmagne S.
    Zhu, Ping
    Jiang, Pengfei
    de Vries, Robbert P.
    Wiley, Cheryl
    Zharkikh, Irina
    Schuelke, Norbert
    Roux, Kenneth H.
    Montefiori, David C.
    Burton, Dennis R.
    Binley, James M.
    VIROLOGY, 2007, 366 (02) : 245 - 262
  • [2] Design and immunogenicity assessment of HIV-1 virus-like particles as a candidate vaccine
    Zhang XiZhen
    Wang XiaoDan
    Zhao DongHai
    Meng XiangYu
    Zhao XingHong
    Yu XiangHui
    Kong Wei
    SCIENCE CHINA-LIFE SCIENCES, 2011, 54 (11) : 1042 - 1047
  • [3] Design and immunogenicity assessment of HIV-1 virus-like particles as a candidate vaccine
    ZHANG XiZhen1
    2Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education of China
    3Jilin Medical College
    Science China(Life Sciences) , 2011, (11) : 1042 - 1047
  • [4] Design and immunogenicity assessment of HIV-1 virus-like particles as a candidate vaccine
    XiZhen Zhang
    XiaoDan Wang
    DongHai Zhao
    XiangYu Meng
    XingHong Zhao
    XiangHui Yu
    Wei Kong
    Science China Life Sciences, 2011, 54 : 1042 - 1047
  • [5] Stabilization of Outer Domain of gp120 from HIV-1 Subtype C for Vaccine Immunogen Design
    Thompson, Jesse
    Kumar, Pankaj
    Yi, Jizu
    Bowder, Dane
    Wood, Charles
    Xiang, Shi-Hua
    PROCEDIA OF THE 8TH VACCINE & ISV CONGRESS, 2015, 9 : 6 - 15
  • [6] Production and immunogenicity of chimeric virus-like particles containing porcine reproductive and respiratory syndrome virus GP5 protein
    Wang, Wei
    Chen, Xiaochun
    Xue, Chunyi
    Du, Yichao
    Lv, Lishan
    Liu, Qiliang
    Li, Xiaoming
    Ma, Yun
    Shen, Huifang
    Cao, Yongchang
    VACCINE, 2012, 30 (49) : 7072 - 7077
  • [7] Immunogenicity of HIV Virus-Like Particles in Rhesus Macaques by Intranasal Administration
    Buonaguro, Luigi
    Tagliamonte, Maria
    Visciano, Maria Luisa
    Andersen, Hanne
    Lewis, Mark
    Pal, Ranajit
    Tornesello, Maria Lina
    Schroeder, Ulf
    Hinkula, Jorma
    Wahren, Britta
    Buonaguro, Franco M.
    CLINICAL AND VACCINE IMMUNOLOGY, 2012, 19 (06) : 970 - 973
  • [8] Design and Characterization of a Peptide Mimotope of the HIV-1 gp120 Bridging Sheet
    Schiavone, Marco
    Fiume, Giuseppe
    Caivano, Antonella
    de Laurentiis, Annamaria
    Falcone, Cristina
    Masci, Francesca Fasanella
    Iaccino, Enrico
    Mimmi, Selena
    Palmieri, Camillo
    Pisano, Antonio
    Pontoriero, Marilena
    Rossi, Annalisa
    Scialdone, Annarita
    Vecchio, Eleonora
    Andreozzi, Concetta
    Trovato, Maria
    Rafay, Jan
    Ferko, Boris
    Montefiori, David
    Lombardi, Angela
    Morsica, Giulia
    Poli, Guido
    Quinto, Ileana
    Pavone, Vincenzo
    de Berardinis, Piergiuseppe
    Scala, Giuseppe
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (05): : 5674 - 5699
  • [9] Immunogenicity of the outer domain of a HIV-1 clade C gp120
    Hongying Chen
    Xiaodong Xu
    Ian M Jones
    Retrovirology, 4
  • [10] Construction and immunogenicity of Salmonella typhimurium vaccine vectors that express HIV-1 gp120
    Fouts, TR
    Tuskan, RG
    Chada, S
    Hone, DM
    Lewis, GK
    VACCINE, 1995, 13 (17) : 1697 - 1705